Replimune (REPL) Total Debt (2019 - 2026)
Replimune (REPL) reported Total Debt of $83.3 million for Q1 2026, up 79.63% on a YoY basis from $46.4 million in Q1 2025, and up 74.91% sequentially from $47.6 million in Q4 2025.
Replimune (REPL) Total Debt (2019 - 2026) Analysis & Trends
Replimune (REPL) has 7 years of Total Debt data on file, last reported at $83.3 million in Q1 2026.
- For the quarter ending Q1 2026, Total Debt rose 79.63% year-over-year to $83.3 million; the trailing twelve-month figure through Mar 2026 stood at $83.3 million (up 79.63% YoY), and the FY2026 full-year result was $83.3 million, up 79.63% from the prior year.
- Total Debt grew to $83.3 million in Q1 2026, from $47.6 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $83.3 million in Q1 2026 to a low of $28.4 million in Q4 2022.
- A 5-year average of $43.7 million and a median of $45.4 million in 2024 frame the typical range for Total Debt.
- Across the five-year window, Total Debt climbed 3.43% in 2024 and jumped 79.63% in 2026, its largest moves.
- Tracing REPL's Total Debt over 5 years: stood at $28.4 million in 2022, then surged by 56.51% to $44.4 million in 2023, then advanced by 3.43% to $46.0 million in 2024, then gained by 3.63% to $47.6 million in 2025, then soared by 74.91% to $83.3 million in 2026.
- Business Quant data shows REPL's Total Debt at $83.3 million in Q1 2026, $47.6 million in Q4 2025, and $47.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 959.06 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Replimune | 970.73 Mn | 970.73 Mn | - | 83.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 83.31 Mn |
| Dec 31, 2025 | 47.63 Mn |
| Sep 30, 2025 | 47.21 Mn |
| Jun 30, 2025 | 46.79 Mn |
| Mar 31, 2025 | 46.38 Mn |
| Dec 31, 2024 | 45.96 Mn |
| Sep 30, 2024 | 45.57 Mn |
| Jun 30, 2024 | 45.19 Mn |
| Mar 31, 2024 | 44.81 Mn |
| Dec 31, 2023 | 44.43 Mn |
| Sep 30, 2023 | 29.16 Mn |
| Jun 30, 2023 | 28.91 Mn |
| Mar 31, 2023 | 28.65 Mn |
| Dec 31, 2022 | 28.39 Mn |
| Sep 30, 2020 | 9.83 Mn |
| Jun 30, 2020 | 9.76 Mn |
| Mar 31, 2020 | 9.80 Mn |
| Dec 31, 2019 | 9.74 Mn |
| Sep 30, 2019 | 9.66 Mn |